North America Tumor Ablation Market to 2024: Top Players Boston Scientific Corporation, Medtronic, Abbott and Tumor Ablation Systems Segment Dominates the Market Share of 67.4%

North America Tumor Ablation Market By Type (Tumor Ablation Systems {Radio Frequency Ablation System, Microwave Ablation System, Cryoablation, High Intensity Focused Ultrasound , Laser Ablation System}, Image Guidance Products, Accessories), By Cancer Type (Liver Cancer, Brain Cancer, Lung Cancer, Bone Cancer, Kidney Cancer, Pancreatic Cancer, Breast Cancer, Others), By Mode of Treatment (Surgical, Laparoscopic, Percutaneous), By End User (Hospitals, Oncology Clinics, Others), Country (U.S., Canada, Mexico)– Industry Trends and Forecast to 2024

Download exclusive PDF sample report @ http://databridgemarketresearch.com/request-a-sample/?dbmr=north-america-tumor-ablation-market

North America Tumor Ablation Market is expected to reach USD 1,248.0 million by 2024 from USD 601.1 million in 2016, at a CAGR of 9.7% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

The major factors driving the growth of this market are the rising number of cancer patients in North America, technological advancement initiatives taken by the key players to innovate new products. On the other hand, high cost of tumor ablation devices may hinder the growth of the market. The tumor ablation market in the North America region is leading in U.S.

Market Segmentation: North America Tumor Ablation Market

The North America tumor ablation market is segmented on the basis of type, cancer type, mode of treatment and end-user. Based on type, the North America tumor ablation market is segmented into tumor ablation systems, image guidance product and accessories. In 2017, tumor ablation systems market segment is expected to account for the largest share of 67.4% of the North America tumor ablation market.

On the basis of cancer type, the North America tumor ablation market is segmented into liver cancer, brain cancer, lung cancer, bone cancer, kidney cancer, pancreatic cancer, breast cancer, and others. In 2017, the breast cancer segment is expected to dominate the market with 30.5% market share.

On the basis of mode of treatment, the North America tumor ablation market is segmented into non-invasive method and invasive method.

By application, the North America tumor ablation market is segmented into antepartum surgical, laparoscopic, and percutaneous. Laparoscopic is the highest growing segment with the highest CAGR of 10.5% in the forecast period 2017 to 2024.

On the basis of end users, the North America tumor ablation market is classified hospitals, oncology clinics, and others. Among these, in 2017 hospitals segment dominated the market and the trend is expected to remain the same till 2024.

Order a copy of North America Tumor Ablation Market Report @ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=north-america-tumor-ablation-market

Key Drivers: North America Tumor Ablation Market

North America is the growing market for tumor ablation. The growth in this market is due to the rising number of cancer patients in North America, technological advancement initiatives taken by the key players to innovate new products. Various product launches in North America market will boost the tumor ablation market.

Technological advancement in the field of early cancer detection will make the demand for tumor ablation.

Key Points: North America Tumor Ablation Market

Medtronic is going to dominate the North America tumor ablation market following with Boston Scientific Corporation and Abbott along with others such as NeuWave Medical, Inc., Koninklijke Philips N.V., INTIO Inc., Mermaid Medical A/S, SonaCare Medical, LLC, DFINE, Inc., Misonix, BVM Medical Limited, AngioDynamics, COMSOL Inc.

Tumor ablation systems segment is expected to dominate the North America tumor ablation market.

The tumor ablation market in the North America region is leading in U.S.

Speak to Experts @ http://databridgemarketresearch.com/speak-to-analyst/?dbmr=north-america-tumor-ablation-market

About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com

This release was published on openPR.